Full text
Earnings transcript
Read the complete earnings call transcript.
BUD
Anheuser-Busch InBev SA/NV
$82.59
1.31
(1.61%)
| Exchange: | NYSE |
| Market Cap: | 163.256B |
| Shares Outstanding: | 689.407M |
Delayed data
About The Company
| Sector: | Consumer DefensiveView sector performance | |||||
| Industry: | Beverages – AlcoholicView industry performance | |||||
| CEO: | Michel Dimitrios Doukeris | |||||
| Full Time Employees: | 136805 | |||||
| Address: |
| |||||
| Website: | https://www.ab-inbev.com |
Anheuser-Busch InBev SA/NV (AB InBev) is a global beverage giant involved in the manufacturing, marketing, and retailing of a wide variety of beers, other alcoholic drinks, and soft drinks across the world. The company manages an expansive collection of around 500 beer labels. Its most prominent and globally recognized brands include Budweiser, Corona, and Stella Artois. Additionally, its portfolio features well-known names such as Beck’s, Hoegaarden, Leffe, and Michelob Ultra, alongside a host of other popular brands like Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol. Established in 1366, AB InBev’s corporate headquarters are situated in Leuven, Belgium.
Click to read more…
Revenue Segmentation
BUD full analysis
Hey everyone, welcome back to the channel! Today, we’re diving deep into a comprehensive analysis of Anheuser-Busch InBev, ticker symbol BUD, one of the biggest players in the global beverage industry. If you’re thinking about investing in this beer giant or just curious about how they’re performing, stick around because we’re breaking down everything from their financials to their market position, and even what the charts are telling us. Let’s get started! Alright, before we jump into the numbers, let’s…
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 59,380,000 | 59,768,000 | 59,320,000 |
| Gross Profit | 31,984,000 | 33,024,000 | 33,179,000 |
| EBITDA | 19,067,000 | 20,296,000 | 20,844,000 |
| Operating Income | 13,966,000 | 15,487,000 | 15,650,000 |
| Net Income | 5,341,000 | 5,855,000 | 6,837,000 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 219,340,000 | 206,637,000 | 218,808,000 |
| Total Liabilities | 126,664,000 | 117,937,000 | 121,071,000 |
| Total Stockholders Equity | 81,848,000 | 78,237,000 | 87,287,000 |
| Total Debt | 78,168,000 | 72,170,000 | 73,027,000 |
| Cash and Cash Equivalents | 10,332,000 | 11,174,000 | 11,638,000 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 13,265,000 | 15,055,000 | 14,929,051.024 |
| Capital Expenditure | -4,638,000 | -3,863,000 | -3,667,312.404 |
| Free Cash Flow | 8,627,000 | 11,192,000 | 11,261,738.620 |
| Net Income | 6,891,000 | 5,855,000 | 6,858,155.066 |
| Net Change in Cash | 424,000 | 860,000 | 464,000 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2030 | Research Access | Research Access | Research Access | Research Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 73,377,639.540 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (High) | 77,302,662.591 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (Avg) | 75,651,181.176 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Low) | 27,784,619.172 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (High) | 29,029,929.508 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Avg) | 28,505,947.842 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Low) | 14,016,015.807 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (High) | 14,999,810.973 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Avg) | 14,585,865.457 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Low) | 22,688,576.219 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (High) | 23,902,204.584 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Avg) | 23,391,561.802 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Avg) | 7.350 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (High) | 7.560 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Low) | 7.060 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated Revenue) | 14 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated EPS) | 4 | Research Access | Research Access | Research Access | Research Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Record Revenue Performance: As highlighted in the 2024 Full Year Earnings Call, AB InBev achieved record-high U.S. dollar revenues, reflecting strong top-line growth and effective execution of its commercial strategies across key markets.
- Operational Efficiency: Key financial metrics such as gross profit margin (TTM) and net profit margin (TTM) indicate robust profitability, supported by operational efficiencies and cost management, positioning the company favorably within the industry.
- Strong Cash Flow Generation: Positive trends in free cash flow (as per Cash Flow Statements) and net cash provided by operating activities demonstrate the company’s ability to generate substantial cash, supporting reinvestment and debt management.
- Global Market Presence: Revenue geographic segments data shows diversified revenue streams across multiple regions, reducing dependency on any single market and enhancing resilience against localized economic downturns.
Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MarketSnap estimates BUD intrinsic value between $105.71 – $133.78 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
Common questions about BUD valuation
Is Anheuser-Busch InBev SA/NV (BUD) overvalued or undervalued right now?
MarketSnap estimates intrinsic value for Anheuser-Busch InBev SA/NV (BUD) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is BUD a buy, hold, or sell for long-term investors?
MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether BUD trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is BUD’s P/E ratio?
You can see BUD’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for BUD?
MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is BUD a good long-term investment?
Whether BUD fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
BUD
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
1.61
Trading Metrics:
| Open: | 82.16 | Previous Close: | 81.28 | |
| Day Low: | 82.09 | Day High: | 83.17 | |
| Year Low: | 59.64 | Year High: | 86.6 | |
| Price Avg 50: | 78.41 | Price Avg 200: | 76.85 | |
| Volume: | 1.834M | Average Volume: | 2.127M |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's free
